CORD-19:e847d433e7424152a9846673209cb73027415ecd / 90140-90462 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T919","span":{"begin":0,"end":322},"obj":"Sentence"},{"id":"T9852","span":{"begin":0,"end":322},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The T.E.S.T. program determined the in vitro activity of tigecycline against strains of Enterobacteriaceae cross-resistant to one or more of the following antimicrobials: amoxicillin-clavulanic acid, piperacillin-tazobactam, levofloxacin, ceftriaxone, cefepime, ampicillin, amikacin, minocycline, ceftazidime and imipenem."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T472","span":{"begin":0,"end":322},"obj":"Sentence"}],"text":"The T.E.S.T. program determined the in vitro activity of tigecycline against strains of Enterobacteriaceae cross-resistant to one or more of the following antimicrobials: amoxicillin-clavulanic acid, piperacillin-tazobactam, levofloxacin, ceftriaxone, cefepime, ampicillin, amikacin, minocycline, ceftazidime and imipenem."}